Norristown, PA, July 9, 2020 – Myoderm, a leading global clinical trial supply company, broke ground for their new global headquarters and US operational facility on a 14-acre site in Horsham, Pa.
“This new facility is the next stage of our evolving support for clinical drug development,” James Lovett, Myoderm’s Chief Executive Officer, said at the groundbreaking on July 9. “It will greatly expand our existing drug storage and distribution capability, especially for cold-chain biologics, and will support our rapidly growing newer services in packaging and labeling, clinical trial equipment and supplies, and CTRx prescription cards for use in clinical trials.”
The 65,000-square-foot facility will include 20,000-sq.-ft. of office space and a 45,000-sq.-ft. warehouse and distribution center with staging, shipping and receiving areas; rack storage in ambient temperatures and 2–8-degree Celsius cold box; -20-degree C and -80-degree C freezer storage; and secondary labeling rooms, all designed to current good manufacturing practices (cGMP) guidelines.